Compare BSBK & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BSBK | KRMD |
|---|---|---|
| Founded | 1893 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.6M | 138.5M |
| IPO Year | 2019 | 2019 |
| Metric | BSBK | KRMD |
|---|---|---|
| Price | $9.07 | $3.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 1.8K | ★ 254.6K |
| Earning Date | 11-02-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 200.00 | 53.85 |
| EPS | ★ 0.12 | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | N/A | $17.22 |
| P/E Ratio | $76.08 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $8.10 | $2.86 |
| 52 Week High | $9.55 | $6.61 |
| Indicator | BSBK | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.04 | 45.35 |
| Support Level | $9.02 | $2.86 |
| Resistance Level | $9.20 | $3.41 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 75.48 | 64.29 |
Bogota Financial Corp is a New Jersey-based bank. It offers personal and business banking services such as savings, certificates of deposits, online banking, loans, and many more. The Bank generally grants residential, commercial, and consumer loans to, and accepts deposits from, customers in New Jersey. The Company operates one reportable segment of business, retail banking. Through its community banking segment, the Company provides a broad range of retail and commercial banking services.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.